NCT04377932 2026-01-21Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsBaylor College of MedicinePhase 1 Active not recruiting14 enrolled 12 charts
NCT06198296 2025-11-03Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T CellsBaylor College of MedicinePhase 1 Recruiting21 enrolled
NCT04715191 2025-05-02Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsBaylor College of MedicinePhase 1 Recruiting24 enrolled
NCT00003107 2014-09-10Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsIndiana UniversityPhase 1 Completed
NCT00004604 2013-02-22Biological Therapy in Treating Patients With Metastatic CancerDuke UniversityPhase 1 Completed24 enrolled